About: Severe atypical pneumonia in critically ill patients: a retrospective multicenter study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Severe atypical pneumonia in critically ill patients: a retrospective multicenter study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Severe atypical pneumonia in critically ill patients: a retrospective multicenter study
Creator	Azoulay, E Razazi, K Argaud, L Bele, N Biard, L Bigé, N Boissier, F Brulé, N Bruneel, F Kouatchet, A Lautrette, A Lemiale, V Lesieur, O Mayaux, J Megarbane, B Moreau, A Oziel, J Papazian, L Perez, P Peyrony, O Pène, F Rouleau, S Seguin, A Valade, S
Source	Medline; PMC
abstract	BACKGROUND: Chlamydophila pneumoniae (CP) and Mycoplasma pneumoniae (MP) patients could require intensive care unit (ICU) admission for acute respiratory failure. METHODS: Adults admitted between 2000 and 2015 to 20 French ICUs with proven atypical pneumonia were retrospectively described. Patients with MP were compared to Streptococcus pneumoniae (SP) pneumonia patients admitted to ICUs. RESULTS: A total of 104 patients were included, 71 men and 33 women, with a median age of 56 [44–67] years. MP was the causative agent for 76 (73%) patients and CP for 28 (27%) patients. Co-infection was documented for 18 patients (viruses for 8 [47%] patients). Median number of involved quadrants on chest X-ray was 2 [1–4], with alveolar opacities (n = 61, 75%), interstitial opacities (n = 32, 40%). Extra-pulmonary manifestations were present in 34 (33%) patients. Mechanical ventilation was required for 75 (72%) patients and vasopressors for 41 (39%) patients. ICU length of stay was 16.5 [9.5–30.5] days, and 11 (11%) patients died in the ICU. Compared with SP patients, MP patients had more extensive interstitial pneumonia, fewer pleural effusion, and a lower mortality rate [6 (8%) vs. 17 (22%), p = 0.013]. According MCA analysis, some characteristics at admission could discriminate MP and SP. MP was more often associated with hemolytic anemia, abdominal manifestations, and extensive chest radiograph abnormalities. SP-P was associated with shock, confusion, focal crackles, and focal consolidation. CONCLUSION: In this descriptive study of atypical bacterial pneumonia requiring ICU admission, mortality was 11%. The comparison with SP pneumonia identified clinical, laboratory, and radiographic features that may suggest MP or CP pneumonia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13613-018-0429-z) contains supplementary material, which is available to authorized users.
has issue date	2018-08-13(xsd:dateTime)
bibo:doi	10.1186/s13613-018-0429-z
bibo:pmid	30105627
has license	cc-by
sha1sum (hex)	76f9e58fe7a4be360490151b1d2fdeba380c1603
schema:url	https://doi.org/10.1186/s13613-018-0429-z
resource representing a document's title	Severe atypical pneumonia in critically ill patients: a retrospective multicenter study
has PubMed Central identifier	PMC6089852
has PubMed identifier	30105627
schema:publication	Ann Intensive Care
resource representing a document's body	covid:76f9e58fe7a4be360490151b1d2fdeba380c1603#body_text
is schema:about of	named entity 'CHLAMYDOPHILA PNEUMONIAE' named entity 'MYCOPLASMA PNEUMONIAE' named entity 'RETROSPECTIVE' named entity 'PATIENTS' named entity 'ATYPICAL PNEUMONIA' named entity 'PATIENTS' named entity 'BACKGROUND' named entity 'ACUTE RESPIRATORY FAILURE' named entity 'INTENSIVE CARE UNIT' named entity 'ADMISSION' named entity 'SEVERE' named entity 'MULTICENTER STUDY' named entity 'CRITICALLY ILL' covid:arg/76f9e58fe7a4be360490151b1d2fdeba380c1603 named entity 'Mycoplasma pneumoniae' named entity 'acute respiratory failure' named entity 'intensive care unit' named entity 'critically ill patients' named entity 'length of stay' named entity 'severe respiratory failure' named entity 'HIV infection' named entity 'organ failure' named entity 'Pneumocystis jirovecii' named entity 'chest X-ray' named entity 'ICU' named entity 'correspondence analysis' named entity 'ICU' named entity 'interstitial lung disease' named entity 'solid cancer' named entity 'LOS' named entity 'nonparametric test' named entity 'antibiotic' named entity 'antibiotics' named entity 'renal replacement therapy' named entity 'Antibiotics' named entity 'troponin' named entity 'Streptococcus pneumoniae' named entity 'antibiotic' named entity 'pyogenic' named entity 'ICU' named entity 'pneumonia' named entity 'community-acquired' named entity 'chest radiograph' named entity 'breath sounds' named entity 'PCR' named entity 'Staphylococcus aureus' named entity 'long-term oxygen therapy' named entity 'third-generation cephalosporin' named entity 'Immunosuppression' named entity 'ICU' named entity 'serological testing' named entity 'neurological' named entity 'asthma' named entity 'comorbidities' named entity 'hemolytic anemia' named entity 'hemolytic anemia' named entity 'inflammation' named entity 'cardiac dysfunction'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software